176 related articles for article (PubMed ID: 34438013)
41. Exogenous Vitamin C-Triggered Surface Charge Conversion of pH/Reduction-Responsive Micelles for the Enhanced Tumor-Specific Activity of Loaded Doxorubicin.
Wu Z; Chen B; Gan Z; Chen F; Luo X
Mol Pharm; 2020 Mar; 17(3):954-964. PubMed ID: 31977226
[TBL] [Abstract][Full Text] [Related]
42. Mitochondria and Nucleus Dual Delivery System To Overcome DOX Resistance.
Cui H; Huan ML; Ye WL; Liu DZ; Teng ZH; Mei QB; Zhou SY
Mol Pharm; 2017 Mar; 14(3):746-756. PubMed ID: 28146635
[TBL] [Abstract][Full Text] [Related]
43. Folate-conjugated amphiphilic hyperbranched block copolymers based on Boltorn H40, poly(L-lactide) and poly(ethylene glycol) for tumor-targeted drug delivery.
Prabaharan M; Grailer JJ; Pilla S; Steeber DA; Gong S
Biomaterials; 2009 Jun; 30(16):3009-19. PubMed ID: 19250665
[TBL] [Abstract][Full Text] [Related]
44. Nanomicelles based on a boronate ester-linked diblock copolymer as the carrier of doxorubicin with enhanced cellular uptake.
Xu Y; Lu Y; Wang L; Lu W; Huang J; Muir B; Yu J
Colloids Surf B Biointerfaces; 2016 May; 141():318-326. PubMed ID: 26874117
[TBL] [Abstract][Full Text] [Related]
45. Surface-Modified Nanoerythrocyte Loading DOX for Targeted Liver Cancer Chemotherapy.
Wang Y; Chen X; He D; Zhou Y; Qin L
Mol Pharm; 2018 Dec; 15(12):5728-5740. PubMed ID: 30359027
[TBL] [Abstract][Full Text] [Related]
46. Stacking of doxorubicin on folic acid-targeted multiwalled carbon nanotubes for in vivo chemotherapy of tumors.
Yan Y; Wang R; Hu Y; Sun R; Song T; Shi X; Yin S
Drug Deliv; 2018 Nov; 25(1):1607-1616. PubMed ID: 30348025
[TBL] [Abstract][Full Text] [Related]
47. Folate and TAT peptide co-modified liposomes exhibit receptor-dependent highly efficient intracellular transport of payload in vitro and in vivo.
Zhu Y; Cheng L; Cheng L; Huang F; Hu Q; Li L; Tian C; Wei L; Chen D
Pharm Res; 2014 Dec; 31(12):3289-303. PubMed ID: 24858397
[TBL] [Abstract][Full Text] [Related]
48. pH-sensitive Au-BSA-DOX-FA nanocomposites for combined CT imaging and targeted drug delivery.
Huang H; Yang DP; Liu M; Wang X; Zhang Z; Zhou G; Liu W; Cao Y; Zhang WJ; Wang X
Int J Nanomedicine; 2017; 12():2829-2843. PubMed ID: 28435261
[TBL] [Abstract][Full Text] [Related]
49. Characterization and evaluation of a folic acid receptor-targeted cyclodextrin complex as an anticancer drug delivery system.
Xu J; Xu B; Shou D; Qin F; Xu Y; Hu Y
Eur J Pharm Sci; 2016 Feb; 83():132-42. PubMed ID: 26577995
[TBL] [Abstract][Full Text] [Related]
50. Mitoxantrone- and Folate-TPGS2k Conjugate Hybrid Micellar Aggregates To Circumvent Toxicity and Enhance Efficiency for Breast Cancer Therapy.
Guissi NE; Li H; Xu Y; Semcheddine F; Chen M; Su Z; Ping Q
Mol Pharm; 2017 Apr; 14(4):1082-1094. PubMed ID: 28191959
[TBL] [Abstract][Full Text] [Related]
51. All-Trans Retinoic Acid and Doxorubicin Delivery by Folic Acid Modified Polymeric Micelles for the Modulation of Pin1-Mediated DOX-Induced Breast Cancer Stemness and Metastasis.
Liu Y; Yu F; Dai S; Meng T; Zhu Y; Qiu G; Wen L; Zhou X; Yuan H; Hu F
Mol Pharm; 2021 Nov; 18(11):3966-3978. PubMed ID: 34579532
[TBL] [Abstract][Full Text] [Related]
52. Doxorubicin-Loaded Micelles Based on Folic Acid Conjugated pH-Dependent Thermo-Sensitive Copolymer: In Vitro and In Vivo Evaluation.
Zhao H; Tao L; Yu R; Yuan H; Lan M
J Nanosci Nanotechnol; 2015 Aug; 15(8):5553-8. PubMed ID: 26369116
[TBL] [Abstract][Full Text] [Related]
53. Gold nanoparticles with a monolayer of doxorubicin-conjugated amphiphilic block copolymer for tumor-targeted drug delivery.
Prabaharan M; Grailer JJ; Pilla S; Steeber DA; Gong S
Biomaterials; 2009 Oct; 30(30):6065-75. PubMed ID: 19674777
[TBL] [Abstract][Full Text] [Related]
54. Antitumor activity of a folate receptor-targeted immunoglobulin G-doxorubicin conjugate.
Yang T; Xu L; Li B; Li W; Ma X; Fan L; Lee RJ; Xu C; Xiang G
Int J Nanomedicine; 2017; 12():2505-2515. PubMed ID: 28408821
[TBL] [Abstract][Full Text] [Related]
55. Targeted Tumor Therapy Based on Nanodiamonds Decorated with Doxorubicin and Folic Acid.
Ryu TK; Baek SW; Lee GJ; Rhee CK; Choi SW
Macromol Biosci; 2017 Feb; 17(2):. PubMed ID: 27654011
[TBL] [Abstract][Full Text] [Related]
56. Antitumor effect of folate-targeted liposomal doxorubicin in KB tumor-bearing mice after intravenous administration.
Riviere K; Huang Z; Jerger K; Macaraeg N; Szoka FC
J Drug Target; 2011 Jan; 19(1):14-24. PubMed ID: 20353291
[TBL] [Abstract][Full Text] [Related]
57. A novel doxorubicin loaded folic acid conjugated PAMAM modified with borneol, a nature dual-functional product of reducing PAMAM toxicity and boosting BBB penetration.
Xu X; Li J; Han S; Tao C; Fang L; Sun Y; Zhu J; Liang Z; Li F
Eur J Pharm Sci; 2016 Jun; 88():178-90. PubMed ID: 26965003
[TBL] [Abstract][Full Text] [Related]
58. Facile synthesis of multi-walled carbon nanotube via folic acid grafted nanoparticle for precise delivery of doxorubicin.
Uttekar PS; Lakade SH; Beldar VK; Harde MT
IET Nanobiotechnol; 2019 Sep; 13(7):688-696. PubMed ID: 31573537
[TBL] [Abstract][Full Text] [Related]
59. cRGD-functionalized reduction-sensitive shell-sheddable biodegradable micelles mediate enhanced doxorubicin delivery to human glioma xenografts in vivo.
Zhu Y; Zhang J; Meng F; Deng C; Cheng R; Feijen J; Zhong Z
J Control Release; 2016 Jul; 233():29-38. PubMed ID: 27178807
[TBL] [Abstract][Full Text] [Related]
60. Development of novel biofunctionalized chitosan decorated nanocochleates as a cancer targeted drug delivery platform.
Bothiraja C; Rajput N; Poudel I; Rajalakshmi S; Panda B; Pawar A
Artif Cells Nanomed Biotechnol; 2018; 46(sup1):447-461. PubMed ID: 29368543
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]